Cancer with low cathepsin D levels is susceptible to vacuolar (H⁺)‐ATPase inhibition

Abstract

Vacuolar (H+)‐ATPases (V‐ATPases) have important roles in the supply of nutrients to tumors by mediating autophagy and the endocytic uptake of extracellular fluids. Accordingly, V‐ATPases are attractive therapeutic targets for cancer. However, the clinical use of V‐ATPase inhibitors as anticancer drugs has not been realized, possibly owing to their high toxicity in humans. Inhibition of V‐ATPase may be an appropriate strategy in highly susceptible cancers. In this study, we explored markers of V‐ATPase inhibitor sensitivity. V‐ATPase inhibitors led to pH impairment in acidic intracellular compartments, suppression of macropinocytosis, and decreased intracellular amino acid levels. The sensitivity of cells to V‐ATPase inhibitors was correlated with low cathepsin D expression, and cancer cells showed increased sensitivity to V‐ATPase inhibitors after pretreatment with a cathepsin D inhibitor and siRNA targeting the cathepsin D gene (CTSD). In addition, V‐ATPase inhibitor treatment led to the induction of the amino acid starvation response, upregulation of endoplasmic reticulum stress markers, and suppression of mammalian target of rapamycin (mTOR) signaling in cells expressing low levels of cathepsin D. Some colorectal cancer patients showed the downregulation of cathepsin D in tumor tissues compared with matched normal tissues. These findings indicate that V‐ATPase inhibitors are promising therapeutic options for cancers with downregulated cathepsin D.

Macropinocytosis: A Metabolic Adaptation to Nutrient Stress in Cancer

“…Furthermore, protein degradation of macropinocytosed albumin was prevented by treatment with bafilomycin A1 in KRAS -mutant PDAC cells ( 10 ). Interestingly, bafilomycin A1 also inhibits the initial stages of macropinocytosis in HRAS -mutant T24 bladder cells ( 53 ), as well as in KRAS -mutant A549 lung cells ( 54 ). These effects of bafilomycin on nascent macropinosome formation may be a result of either (1) perturbations of cytosolic pH due to impaired pumping of protons into lysosomes or (2) alterations of submembranous pH due to inhibition of proton pumping to the extracellular space.…”

Investigation of Metabolomic Changes in Sunitinib-Resistant Human Renal Carcinoma 786-O Cells by Capillary Electrophoresis-Time of Flight Mass Spectrometry

“…4) Previous studies have shown that several metabolic changes take place in the cell during the acquisition of drug resistance. 5,6) Recent advances in both instrumental and computational metabolomic technologies have enabled metabolite profiling studies by NMR spectroscopy, 7) GC-MS, 8,9) LC-MS, 10) and capillary electrophoresis-time of flight (CE-TOF)MS. [11][12][13] As most of the primary metabolites are polar compounds, CE-TOFMS is suitable for separating them from their principle and the superior separation performance is shown by a high theoretical plate number. 14) Even structural isomers (e.g.…”

Uncovering the Mechanism of Shenlian Capsules in the Treatment of Non-small Cell Lung Cancer by System Pharmacology

“…CTSD protein is a kind of cathepsin. CTSD can directly catalyze the degradation of extracellular matrix and extrabasal membrane, participate in the proteolytic cascade, jointly promote tumor growth, invasion and metastasis [52]. Our research shows that CTSD expression is inversely related to patient survival time.…”